We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA DESIGNATES CCC SYSTEMS AS CLASS II, ISSUES GUIDANCE
FDA DESIGNATES CCC SYSTEMS AS CLASS II, ISSUES GUIDANCE
May 14, 2004
The FDA issued a final rule May 10 designating the immunomagnetic circulating cancer cell (CCC) selection and enumeration system as a Class II device with special controls.